Sunshine Biopharma Inc. SEC filings SBFMW
Sunshine Biopharma Inc. has 428 filings in SEC EDGAR's recent list, going back to May 25, 2007. Its latest annual report, Form 10-K, was filed on Apr 3, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 14, 2026 (shareholder vote results). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Oct 7, 2026 | — |
| DRS | Filing | Sep 24, 2026 | — |
| EFFECT | Filing | Sep 8, 2026 | — |
| EFFECT | Filing | May 18, 2026 | — |
| CORRESP | Letter to the SEC | May 18, 2026 | — |
| CORRESP | Letter to the SEC | May 18, 2026 | — |
| CORRESP | Letter to the SEC | May 14, 2026 | — |
| CORRESP | Letter to the SEC | May 14, 2026 | — |
| UPLOAD | Letter from the SEC | May 4, 2026 | — |
| DRSLTR | Filing | Apr 28, 2026 | — |
| DRS | Filing | Apr 28, 2026 | — |
| NT 10-K | Extension | Mar 31, 2026 | Dec 31, 2025 |
| EFFECT | Filing | Aug 12, 2025 | — |
| RW | Form rw | Aug 12, 2025 | — |
| UPLOAD | Letter from the SEC | Aug 11, 2025 | — |
| CORRESP | Letter to the SEC | Aug 11, 2025 | — |
| NT 10-K | Filing | Mar 31, 2025 | Dec 31, 2024 |
| EFFECT | Filing | Jan 15, 2025 | — |
| CORRESP | Letter to the SEC | Jan 13, 2025 | — |
| UPLOAD | Letter from the SEC | Jan 13, 2025 | — |
| EFFECT | Filing | Nov 8, 2024 | — |
| NT 10-Q | Request for extension | Aug 14, 2024 | Jun 30, 2024 |
| NT 10-Q | Extension | May 15, 2024 | Mar 31, 2024 |
| EFFECT | Filing | Feb 12, 2024 | — |
| CORRESP | Letter to the SEC | Feb 9, 2024 | — |
| CORRESP | Letter to the SEC | Feb 9, 2024 | — |
| UPLOAD | Letter from the SEC | Feb 6, 2024 | — |
| UPLOAD | Letter from the SEC | Aug 29, 2023 | — |
| CORRESP | Letter to the SEC | Aug 8, 2023 | — |
| UPLOAD | Letter from the SEC | Jul 25, 2023 | — |
| EFFECT | Filing | Jun 5, 2023 | — |
| CORRESP | Letter to the SEC | Jun 1, 2023 | — |
| UPLOAD | Letter from the SEC | Jun 1, 2023 | — |
| D | Filing | May 17, 2023 | — |
| NT 10-K | Filing | Mar 31, 2023 | Dec 31, 2022 |
| EFFECT | Filing | May 20, 2022 | — |
| CORRESP | Letter to the SEC | May 18, 2022 | — |
| UPLOAD | Letter from the SEC | May 18, 2022 | — |
| D | Filing | Apr 29, 2022 | — |
| EFFECT | Filing | Apr 8, 2022 | — |
| CORRESP | Letter to the SEC | Apr 7, 2022 | — |
| UPLOAD | Letter from the SEC | Apr 7, 2022 | — |
| D | Filing | Mar 18, 2022 | — |
| EFFECT | Filing | Feb 14, 2022 | — |
| CERT | 8a cert | Feb 11, 2022 | — |
| 8-A12B | Form 8-a12b | Feb 10, 2022 | — |
| CORRESP | Letter to the SEC | Feb 9, 2022 | — |
| CORRESP | Letter to the SEC | Feb 9, 2022 | — |
| UPLOAD | Letter from the SEC | Sep 16, 2021 | — |
| NT 10-Q | Filing | Aug 14, 2020 | Jun 30, 2020 |
| NT 10-Q | Filing | May 15, 2020 | Mar 31, 2020 |
| DEFR14C | Filing | Apr 2, 2020 | — |
| NT 10-K | Filing | Mar 30, 2020 | Dec 31, 2019 |
| NT 10-Q | Filing | Aug 14, 2019 | Jun 30, 2019 |
| NT 10-Q | Filing | May 14, 2019 | Mar 31, 2019 |
| NT 10-K | Filing | Mar 29, 2019 | Dec 31, 2018 |
| NT 10-Q | Primary document | Nov 14, 2018 | Sep 30, 2018 |
| RW | Filing | Oct 31, 2018 | — |
| DEL AM | Filing | Oct 17, 2018 | — |
| NT 10-Q | Late filing notification | Aug 14, 2018 | Jun 30, 2018 |
| NT 10-Q | Filing | May 15, 2018 | Mar 31, 2018 |
| NT 10-Q | Late filing notification | Nov 13, 2017 | Sep 30, 2017 |
| NT 10-K | Filing | Mar 30, 2017 | Dec 31, 2016 |
| NT 10-Q | Notification of late filing | Aug 15, 2016 | Jun 30, 2016 |
| EFFECT | Filing | Jul 23, 2014 | — |
| CORRESP | Letter to the SEC | Jul 21, 2014 | — |
| CORRESP | Letter to the SEC | Jul 2, 2014 | — |
| UPLOAD | Letter from the SEC | Jun 20, 2014 | — |
| RW | Request to withdraw registration statement | Apr 29, 2014 | — |
| RW | Registration withdrawal | Jan 22, 2014 | — |
| D | Filing | Aug 24, 2012 | — |
| UPLOAD | Letter from the SEC | Feb 7, 2012 | — |
| CORRESP | Letter to the SEC | Feb 7, 2012 | — |
| UPLOAD | Letter from the SEC | Feb 6, 2012 | — |
| UPLOAD | Letter from the SEC | Jul 2, 2010 | — |
| DEFR14C | Revised definitive schedule 14c | Jun 21, 2010 | — |
| CORRESP | Letter to the SEC | May 28, 2010 | — |
| CORRESP | Letter to the SEC | May 13, 2010 | — |
| UPLOAD | Letter from the SEC | May 3, 2010 | — |
| NT 10-Q | Notification of late filing of form 10-q | Mar 16, 2010 | Jan 31, 2010 |
| NT 10-Q | Notification of late filing of form 10-q | Dec 15, 2009 | Oct 31, 2009 |
| SC 14F1 | Schedule 14f-1 | Oct 23, 2009 | — |
| 10KSB | Annual report for year ended july 31, 2008 | Oct 28, 2008 | Jul 31, 2008 |
| 10QSB/A | Amendment #1 to 10-qsb ended 1-31-08 | Jun 12, 2008 | Jan 31, 2008 |
| 10QSB/A | Amendment #2 to 10-qsb ended 10-31-07 | Jun 12, 2008 | Oct 31, 2007 |
| 10KSB/A | Amendment #2 to 10-ksb fye 7/31/2007 | Jun 12, 2008 | Jul 31, 2007 |
| 10QSB | Quarterly report for period ended 4/30/2008 | Jun 4, 2008 | Apr 30, 2008 |
| 10QSB | Quarterly report for period ended 1/31/2008 | Apr 2, 2008 | Jan 31, 2008 |
| 10QSB/A | Amendment #1 - form 10-qsb/a | Feb 21, 2008 | Oct 31, 2007 |
| 10KSB/A | Amendment #1 to report 10-ksb | Feb 21, 2008 | Jul 31, 2007 |
| RW | Registration withdrawal | Feb 14, 2008 | — |
| 10QSB | 10-qsb first quarter 10-31-2007 | Dec 14, 2007 | Oct 31, 2007 |
| 10KSB | Report 10-ksb | Nov 13, 2007 | Jul 31, 2007 |
| 8-A12G | Form 8a12g | Nov 7, 2007 | — |
| EFFECT | Filing | Nov 5, 2007 | — |
| SB-2 | Filing | Oct 19, 2007 | — |
| REGDEX | Auto-generated paper document | May 25, 2007 | — |
Showing 97 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- SBFM (Nasdaq), SBFMW (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- CO
- Headquarters
- Fort Lauderdale, FL
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1402328
- Former names
- Sunshine Biopharma, Inc (until Oct 17, 2024); Mountain West Business Solutions, Inc (until Nov 2, 2009); mountain west business solutions,inc (until Oct 19, 2007); mountain state business solutions,inc (until May 25, 2007)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.